# Nasdaq Roulette: Splits, Trends, and Market Madness!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2026-07-23T14:00:00.259Z
Source: https://newsyai.com/edition/b392db04-7dd8-4710-9552-5acc4d23435c
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

**Nasdaq’s Reverse-Split Roulette: Diabetes Dildos, Fashion Fades & EV Pipe Dreams – July 23, 2026 Edition!**

Futures mixed (Dow snoozing, Nasdaq still sucking on the AI/chip tit while crude oil flexes like it owns the joint). July 22’s carnage fades into the rearview; the reverse-split guillotine keeps dropping with zero extra lube for repeat offenders under Nasdaq’s tightened rules. Retail degens are foaming for that post-split stiffy while bears sharpen the dilution blades. Balls-deep into three fresh volatility junkies where bulls and bears are screaming past each other like drunk traders at a closing-bell orgy.[[1]](https://www.stocktitan.net/news/stock-splits.html)

### 1) Trinity Biotech plc (TRIB): “1-for-30 HIV Test Dream vs. Serial Splitter & Cash-Burn Graveyard”

**Why it’s loud**  
1-for-30 reverse split (ADS ratio change) effective July 24, 2026, to claw back the $1 Nasdaq bid after prior 1-for-5 moves. Diabetes diagnostics and rapid HIV test play hyped as healthcare necessity. Bulls drool over any diagnostic tailwinds or niche test demand with a shrunken float; bears hammer chronic dilution, execution flops, and “microcap autopsy” energy.[[2]](https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-516)

**Bull case (compliance rocket + test stiffy)**  
Massive ratio + volume spike + any positive health news or buyout chatter = $1–4+ rip. Ride the diagnostic fantasy, apes—narrative rocket fuel on the tighter float!

**Bear case (dilution gangbang & split limp encore)**  
30x desperation screams ongoing capital needs, brutal competition in diagnostics, repeated raises = sub-$0.05 graveyard. Short the fade before the next offering tsunami!

**My take, first principles (real test signal vs. listing cancer)**  
Genuine niche in rapid diagnostics offers short-term narrative juice in healthcare, but repeat reverse-split history, dilution overhang, stricter Nasdaq rules, and microcap volatility scream unsustainable trap. Real operational niche with lottery vibes. Scalp the spunk? **$0.09–1.60** range, **$0.42C** test pump—**P$0.07** dilution fade.

### 2) Digital Brands Group Inc. (DBGI): “1-for-40 Apparel Recovery Dream vs. Chronic Dilution & Float Shrink to Nothing”

**Why it’s loud**  
1-for-40 reverse split effective July 24, 2026, for Nasdaq $1 bid compliance. Digital fashion/apparel brands play hyped as retail recovery story. Bulls hype any consumer spending bounce or brand hype with tiny post-split float; bears pound serial dilution, massive prior collapses, and “microcap graveyard” vibes.[[3]](https://www.stocktitan.net/sec-filings/DBGI/8-k-digital-brands-group-inc-reports-material-event-922fddf344d3.html)

**Bull case (compliance rocket + fashion boner)**  
Insane ratio + volume spike + any positive retail/fashion news = $1–5+ rip. Ride the brand fantasy, degens!

**Bear case (dilution gangbang & split limp encore)**  
40x desperation screams ongoing capital needs, brutal competition in apparel, repeated raises = sub-$0.04 graveyard. Short the fade before the next offering tsunami!

**My take, first principles (real fashion signal vs. listing cancer)**  
Genuine digital brand play offers short-term narrative juice in consumer goods, but microcap volatility, extreme 40x move, dilution overhang, and Nasdaq scrutiny scream trap. Real operational niche with token risk. Scalp it? **$0.08–2.00** range, **$0.45C** fashion pump—**P$0.06** dilution fade.

### 3) Faraday Future Intelligent Electric Inc. (FFAI): “1-for-150 EV/AI Clown Car Dream vs. Epic Dilution & Delisting Doom”

**Why it’s loud**  
Insane 1-for-150 reverse split effective July 24, 2026, to preserve Nasdaq listing after prior massive splits. Embodied AI/EV ecosystem play hyped as futuristic tech savior. Bulls eye any EV/AI hype or partnership news with shrunken float; bears hammer governance nightmares, cash burn, and “EV graveyard” energy.[[4]](https://www.businesswire.com/news/home/20260721185843/en/Faraday-Future-NASDAQFFAI-Announces-1-for-150-Reverse-Stock-Split-Effective-at-the-Open-of-Trading-on-July-24-2026)

**Bull case (compliance rocket + future boner)**  
Nuclear ratio + volume spike + any EV/AI breakthrough = $1–6+ rip. Ride the sci-fi fantasy, apes!

**Bear case (dilution gangbang & split limp encore)**  
150x desperation screams ongoing capital needs, brutal EV execution risks, repeated raises = sub-$0.03 wipeout. Short the fade before the next offering tsunami!

**My take, first principles (real tech signal vs. listing cancer)**  
Genuine AI/EV narrative offers short-term hype juice, but insane ratio, dilution history, stricter Nasdaq rules, and microcap chaos scream unsustainable trap. Real operational moonshot with lottery vibes. Scalp the spunk? **$0.07–1.80** range, **$0.38C** EV pump—**P$0.05** dilution fade.

**Tape-Side Tactics (TRIB Test Tube, DBGI Threads & FFAI Future Fails – July 23 Edition)**  
- **TRIB**: **$0.09–1.60** stiffy; **$0.42C** test pump, **P$0.07** fade.  
- **DBGI**: **$0.08–2.00** stiffy; **$0.45C** fashion pump, **P$0.06** fade.  
- **FFAI**: **$0.07–1.80** stiffy; **$0.38C** EV pump, **P$0.05** fade.  

New split rules still tightening the noose amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions!

**Sources** (for tracking every claim above):  
- Reverse splits & reactions: Nasdaq Trader Corporate Actions Alerts, Yahoo Finance/StockTitan/GlobeNewswire announcements (July 2026 data).[[2]](https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-516)  
- Company announcements & details: BusinessWire, StockTitan press releases, SEC filings.[[4]](https://www.businesswire.com/news/home/20260721185843/en/Faraday-Future-NASDAQFFAI-Announces-1-for-150-Reverse-Stock-Split-Effective-at-the-Open-of-Trading-on-July-24-2026)  
- Nasdaq reverse-split rule changes & compliance: Federal Register, Norton Rose Fulbright analyses (2025–2026 updates).  
- Broader microcap/premarket context & volatility: Yahoo Finance, recent company filings.
